Literature DB >> 18985

Activity of spectinomycin against anaerobes.

J E Rosenblatt, A M Gerdts.   

Abstract

The in vitro inhibitory activity of spectinomycin was tested against various anaerobic bacteria. Different results were obtained with different media and with different initial pH's of the media. The highest minimum inhibitory concentrations for Bacteroides fragilis ([Formula: see text] 128 mug/ml) were obtained with the use of Wilkins-Chalgren agar (pH 7.2) and Brucella blood agar (pH 7.0). Brucella blood agar at higher pH's (7.4 and 8.0) and Mueller-Hinton and Diagnostic Sensitivity Test agars produced lower minimum inhibitory concentrations (32 and 64 mug/ml). This same relationship between spectinomycin activity and pH of the medium was, in general, observed with these media and other anaerobes, including isolates of B. melaninogenicus, Fusobacterium, gram-positive cocci, Clostridium perfringens, and C. ramosum. The variable results observed in this study and in two others make it difficult to predict the clinical usefulness of spectinomycin in the treatment of anaerobic infections. It is probably most appropriate to be guided by results obtained with Wilkins-Chalgren agar and the method proposed as a reference to the National Committee for Clinical Laboratory Standards. These results indicate that spectinomycin is not a potent inhibitor of B. fragilis or other clinically significant anaerobes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18985      PMCID: PMC352150          DOI: 10.1128/AAC.12.1.37

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  An evaluation of the carbon dioxide component in the GasPak anaerobic system.

Authors:  I R Ferguson; K D Phillips; P V Tearle
Journal:  J Appl Bacteriol       Date:  1975-10

2.  Letter: Bacteroides fragilis and spectinomycin.

Authors:  I R Ferguson; L L Smith
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

3.  Medium for use in antibiotic susceptibility testing of anaerobic bacteria.

Authors:  T D Wilkins; S Chalgren
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

4.  Susceptibility of Bacteroides fragilis to spectinomycin.

Authors:  I Phillips; C Warren
Journal:  J Antimicrob Chemother       Date:  1975-03       Impact factor: 5.790

5.  Absorption, distribution, and elimination of spectinomycin dihydrochloride in man.

Authors:  J G Wagner; E Novak; L G Leslie; C M Metzler
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1968-04

6.  Treatment of gonorrhea with spectinomycin hydrochloride: comparison with standard penicillin schedules.

Authors:  W C Duncan; W R Holder; D P Roberts; J M Knox
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

7.  The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.

Authors:  H R Ingham; J B Selkon; A A Codd; J H Hale
Journal:  J Clin Pathol       Date:  1970-04       Impact factor: 3.411

8.  In vitro antibacterial activity of spectinomycin.

Authors:  I I Washington JA; P K Yu
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

9.  Effect of several components of anaerobic incubation on antibiotic susceptibility test results.

Authors:  J E Rosenblatt; F Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

  9 in total
  1 in total

1.  Derivatives of 4-dihydro-4-deoxy-4(R)-amino spectinomycin and their activity against susceptible and resistant Escherichia coli strains.

Authors:  R G Werner; U L Lechner; H Goeth
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.